Jeffrey W Sherman's Net Worth
$22.7 Million
Who is Jeffrey W Sherman?
Jeffrey W Sherman has an estimated net worth of $22.7 Million. This is based on reported shares across multiple companies, which include HORIZON PHARMA, INC., XERIS PHARMACEUTICALS INC, Xeris Biopharma Holdings, Inc., Strongbridge Biopharma plc, Larimar Therapeutics, Inc., IDM PHARMA, INC., and NEOPHARM INC.
SEC CIK
Jeffrey W Sherman's CIK is 0001230482
Past Insider Trading and Trends
2021 was Jeffrey W Sherman's most active year for acquiring shares with 22 total transactions. Jeffrey W Sherman's most active month to acquire stocks was the month of December. 2023 was Jeffrey W Sherman's most active year for disposing of shares, totalling 27 transactions. Jeffrey W Sherman's most active month to dispose stocks was the month of December. 2004 saw Jeffrey W Sherman paying a total of $598,706.00 for 30,100 shares, this is the most they've acquired in one year. In 2021 Jeffrey W Sherman cashed out on 604,116 shares for a total of $9,578,671.39, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HORIZON PHARMA, INC. No price found
EVP and Chief Medical OfficerJeffrey W Sherman owns 102,596 units of Common Stock. Jeffrey W Sherman used to own units in Ordinary Shares but no longer holds any shares there.acquired a total of 879,930 shares in HORIZON PHARMA, INC. at a cost of $1,392,126.52, Jeffrey also disposed a total of 662,739 shares of HORIZON PHARMA, INC. equalling to $23,536,050.92.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -234.76K |
$116.50 | -$27,349,423.50 |
0
|
Oct 6
| |||
Form 4
| -2.61% | -2.17K |
—
|
—
| 80.94K |
Sep 6
| |||
Form 4
|
—
|
0
|
—
|
—
| 85.48K |
Jan 17
| |||
Form 4
| -15.70% | -6.74K |
$113.07 | -$761,673.20 | 36.17K |
Scheduled
|
Jan 10 - Jan 11
| ||
Form 4
| +33.79% | 23.29K |
$113.27 | -$3,153,087.43 | 92.22K |
Scheduled
|
Jan 4 - Jan 6
| ||
Form 4
| +507.58% | 12.05K |
$113.80 | -$1,105,794.60 | 14.43K |
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 27
| |||
Form 4
| -16.71% | -28.35K |
$111.45 | -$3,159,691.71 | 141.31K |
Scheduled
|
May 27 - Dec 12
| ||
Form 4
| -79.81% | -42.01K |
$110.02 | -$4,621,872.19 | 10.63K |
Scheduled
|
Apr 6
| ||
Form 4
| +8.79% | 8.53K |
$22.14 | $188,876.34 | 105.58K |
May 25 - Mar 18
| |||
Form 4
| +5.30% | 2.98K |
$86.42 | -$204,988.24 | 59.29K |
Jan 21
| |||
Form 4
| +100.48% | 47.15K |
—
|
—
| 94.07K |
Nov 8 - Jan 5
| |||
Form 4
| +117.71% | 10.73K |
$7.61 | $81,647.69 | 19.84K |
Oct 27
| |||
Form 4
|
—
|
0
|
$58.81 | -$4,737,687.69 | 36.19K |
Scheduled
|
Sep 3 - Sep 21
| ||
Form 4
| +44.34% | 4.04K |
$102.50 | -$329,537.50 | 13.16K |
Jul 28
| |||
Form 4
| -22.69% | -60.08K |
$95.00 | -$5,707,362.45 | 204.69K |
Scheduled
|
Mar 10 - Jul 1
| ||
Form 4
| +1.39% | 1.09K |
$87.17 | -$75,925.07 | 80.08K |
Feb 17
| |||
Form 4
| +1.15% | 2.98K |
$77.43 | -$183,663.96 | 262.62K |
Dec 29 - Jan 21
| |||
Form 4
| +202.29% | 56.67K |
$73.28 | -$3,316,359.68 | 84.69K |
Jan 4 - Jan 5
| |||
Form 4
| -37.25% | -103.84K |
$71.02 | -$7,375,214.11 | 174.96K |
Scheduled
|
Dec 7 - Dec 8
| ||
Form 4/A
| +86.58% | 13K |
$7.61 | $98,930.00 | 28.02K |
Oct 21
| |||
Form 4
| +86.58% | 13K |
$7.61 | $98,930.00 | 28.02K |
Oct 21
| |||
Form 4
| -3.16% | -9.10K |
$57.50 | -$523,250.00 | 278.8K |
Scheduled
|
Jul 6
| ||
Form 4
|
—
|
0
|
$24.98 | -$1,340,499.16 | 13.97K |
Scheduled
|
May 11
| ||
Form 4
| +60.92% | 5.29K |
$12.94 | $68,413.78 | 13.97K |
Mar 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +5.32% | 10.72K |
$13.86 | -$118,198.08 | 212.34K |
Mar 23
| |||
Form 4
| +4.04% | 7.82K |
$15.02 | -$115,353.60 | 201.62K |
Jan 2
| |||
Form 4
| +5.75% | 10.45K |
$14.56 | -$128,098.88 | 192.35K |
Mar 23
| |||
Form 4
| +8.43% | 14.15K |
$16.18 | -$203,900.36 | 181.9K |
Jan 2
| |||
Form 4
| +5.34% | 8.5K |
$2.40 | $20,400.00 | 167.75K |
Dec 16
| |||
Form 4
| -1.79% | -2.90K |
$20.00 | -$58,000.00 | 159.25K |
Scheduled
|
Aug 2
| ||
Form 4
| +6.98% | 10.45K |
$16.32 | -$143,583.36 | 160.1K |
Mar 23
| |||
Form 4
| -2.67% | -4.10K |
$20.00 | -$82,000.00 | 149.65K |
Scheduled
|
Feb 26
| ||
Form 4
| +13.41% | 18.17K |
$21.67 | -$185,841.92 | 153.75K |
Jan 2
| |||
Form 4
| +28.96% | 30.44K |
$3.89 | $118,352.32 | 135.57K |
Dec 15
| |||
Form 4
| +4.43% | 4.46K |
$20.00 | $89,120.00 | 105.13K |
Scheduled
|
Dec 10
| ||
Form 4/A
| +4.24% | 4.46K |
$20.40 | -$76,540.80 | 109.59K |
Dec 8
| |||
Form 4
| +4.24% | 4.46K |
$21.40 | -$80,292.80 | 109.59K |
Dec 8
| |||
Form 4
| -6.87% | -7.75K |
$31.78 | -$246,295.00 | 105.13K |
Scheduled
|
Sep 21
| ||
Form 4
|
—
|
0
|
$19.09 | -$885,032.05 | 112.88K |
Scheduled
|
Jul 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 23
| |||
Form 4/A
| +12.32% | 11.25K |
—
|
—
| 102.6K |
Jan 2
| |||
Form 4
| +7.05% | 5.55K |
$12.99 | -$34,501.44 | 84.34K |
Dec 8
| |||
Form 4
| +21.34% | 18K |
$12.80 | -$112,038.40 | 102.33K |
Jan 2
| |||
Form 4
| -25.18% | -25.00K |
$12.05 | -$301,237.95 | 74.3K |
Nov 19
| |||
Form 4
|
∞
| 99.3K |
—
|
—
| 99.3K |
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -100.00% | -99.30K |
—
|
—
|
0
|
Sep 19
| |||
Form 4
| -9.12% | -9.36K |
$12.94 | -$121,131.34 | 93.23K |
Scheduled
|
May 19
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +40.31% | 26.25K |
—
|
—
| 91.35K |
Dec 5 - Dec 9
| |||
Form 4
| +42.03% | 16.3K |
$2.36 | $38,477.44 | 55.1K |
Scheduled
|
Jan 2
| ||
Form 4
| +12.99% | 8.21K |
—
|
—
| 71.4K |
Dec 10
| |||
Form 4
| +117.42% | 33K |
—
|
—
| 61.1K |
Jul 26
| |||
Form 4
|
∞
| 22K |
—
|
—
| 22K |
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
XERIS PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Xeris Biopharma Holdings, Inc. (XERS) Snapshot price: $2.51
InvestorJeffrey W Sherman owns 164,380 units of Common Stock which is worth $412,593.80. From 2021 to 2024 Jeffrey W Sherman acquired a total of 164,380 shares in Xeris Biopharma Holdings, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +43.71% | 50K |
—
|
—
| 164.38K |
Jun 5
| |||
Form 4
| +6.03% | 6.5K |
—
|
—
| 114.38K |
Mar 15
| |||
Form 4
|
∞
| 5.4K |
$1.87 | $10,098.00 | 5.4K |
Nov 27
| |||
Form 4
| +65.01% | 42.5K |
—
|
—
| 107.88K |
Jun 7
| |||
Form 4
| +29.77% | 15K |
—
|
—
| 65.38K |
Jun 8
| |||
Form 4
|
∞
| 50.38K |
—
|
—
| 50.38K |
Oct 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Strongbridge Biopharma plc No price found
InvestorJeffrey W Sherman used to own units in Ordinary Shares but no longer holds any shares there. In the year 2018 Jeffrey W Sherman filed a total of 9 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -64.26K |
—
|
—
|
0
|
Oct 5
| |||
Form 4
| -21.66% | -17.76K |
$2.06 | -$36,591.78 | 64.26K |
Oct 1
| |||
Form 4
| +95.19% | 40K |
—
|
—
| 82.02K |
May 18
| |||
Form 4
| -31.07% | -18.94K |
$2.35 | -$44,518.40 | 42.02K |
May 14
| |||
Form 4
| -23.79% | -19.04K |
$2.86 | -$54,440.10 | 60.97K |
May 15
| |||
Form 4
| +100.00% | 40K |
—
|
—
| 80K |
May 14
| |||
Form 4
|
∞
| 40K |
—
|
—
| 40K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Larimar Therapeutics, Inc. (LRMR) Snapshot price: $8.05
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||